Joint Procedure for the Information Exchange of Serious or Life-Threatening Human / Animal Pharmaceutical Product Quality Defects and Recalls May 2001

Joint Procedure for the Information Exchange of Serious or Life-Threatening Human / Animal Pharmaceutical Product Quality Defects and Recalls May 2001

The purpose of this procedure is to share information in a timely and effective manner so as to minimize the risk to the affected public and maintain confidence in the system. It includes the transmission of information relating to pharmaceutical products with suspected serious quality defects under recall.